The Cartilage Dilemma
Articular cartilage is avascular—it lacks a dedicated blood supply. This is why joint injuries (meniscus tears, osteoarthritis) rarely heal on their own. Traditional medicine offers corticosteroid injections (which degenerate cartilage long-term) or joint replacement.
Peptides represent a shift toward attempting biological preservation and regeneration of the joint capsule by signaling cellular repair mechanisms.
Pentosan Polysulfate (PPS)
Though technically a semi-synthetic macromolecular carbohydrate rather than a pure peptide, PPS (often prescribed under the brand name Elmiron or generic Pentosan) is the gold standard for osteoarthritic regeneration. It stimulates proteoglycan synthesis, improves synovial fluid viscosity, and strongly inhibits enzymes that break down cartilage.
Administered via subcutaneous injection (typically 2mg/kg twice weekly), PPS has shown remarkable ability to reduce bone marrow lesions and halt osteoarthritis progression.
BPC-157 and TB-500 for Joint Support
While PPS targets cartilage specifically, BPC-157 accelerates blood vessel formation (angiogenesis) to deliver nutrients to the joint boundary, while TB-500 (Thymosin Beta-4) upregulates actin, accelerating cell migration into the injury site.
Combining all three creates a synergistic "joint armor" protocol that attacks inflammation, structural tendon weakness, and cartilage degradation simultaneously.
